Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms

References

• SankarRDerdiarianATVigabatrinCNS Drug Reviews19984260274
   Google Scholar
• EkeTTalbotJFLawdenMCSevere persistent visual field constriction associated with vigabatrinBMJ19973141801819022432
   PubMed Web of Science ®Google Scholar
• KraussGLJohnsonMAMillerNRVigabatrin-associated retinal cone system dysfunction: Electroretinogram and ophthalmologic findingsNeurology1998506146189521245
   PubMed Web of Science ®Google Scholar
• ButlerWHFordGPNewberneJWA study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded ratsToxicol Pathol1987151431483616399
   PubMed Web of Science ®Google Scholar
• ShieldsWDInfantile spasms: Little seizures, big consequencesEpilepsy Curr20066636916761063
   PubMedGoogle Scholar
• CowanLDHudsonLSThe epidemiology and natural history of infantile spasmsJ Child Neurol199163553641940138
   PubMed Web of Science ®Google Scholar
• SherrEHThe ARX story (epilepsy, mental retardation, autism, and cerebral malformations): One gene leads to many phenotypesCurr Opin Pediatr20031556757114631200
   PubMed Web of Science ®Google Scholar
• KatoMA new paradigm for West syndrome based on molecular and cell biologyEpilepsy Res200670SS879516806828
   PubMed Web of Science ®Google Scholar
• FuscoLVigevanoFIctal clinical electroencephalographic findings of spasms in West syndromeEpilepsia1993346716788330577
   PubMed Web of Science ®Google Scholar
• WhelessJWClarkeDFArzimanoglouATreatment of pediatric epilepsy: European expert opinionEpileptic Disord2007935341218077226
   PubMed Web of Science ®Google Scholar
• MackayMTWeissSKAdams-WebberTPractice parameter: Medical treatment of infantile spasms: Report of the American Academy of Neurology and the Child Neurology SocietyNeurology2004621668168115159460
   PubMed Web of Science ®Google Scholar
• Sabril (vigabatrin)Highlights of prescribing informationDeerfield, ILLundbeck Inc2009 Available from: http://www.lundbeckshare.com/pg510_info_physicians.aspxAccessed on 2010 Jul 29
   Google Scholar
• JungMJLippertBMetcalfBWBohlenPSchechterPJGamma-vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effects on brain GABA metabolism in miceJ Neurochem197729797802591956
   PubMed Web of Science ®Google Scholar
• SchechterPJTranierYJungMJBohlenPAudiogenic seizure protection by elevated brain GABA concentration in mice: Effects of gamma-acetylenic GABA and gamma-vinyl GABA, two irreversible GABA-T inhibitorsEur J Pharmacol197745319328923642
   PubMed Web of Science ®Google Scholar
• BernasconiRKleinMMartinPGamma-vinyl GABA: Comparison of neurochemical and anticonvulsant effects in miceJ Neural Transm1988722132333418334
   PubMed Web of Science ®Google Scholar
• MattsonRHPetroffORothmanDBeharKVigabatrin: Effects on human brain GABA levels by nuclear magnetic resonance spectroscopyEpilepsia199435Suppl 5S29328039467
   PubMed Web of Science ®Google Scholar
• PetroffOARothmanDLBeharKLMattsonRHInitial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brainEpilepsia1995364574647614922
   PubMed Web of Science ®Google Scholar
• KerriganJFShieldsWDNelsonTYGanaxolone for treating intractable infantile spasms: A multicenter, open-label, add-on trialEpilepsy Res20004213313911074186
   PubMed Web of Science ®Google Scholar
• DreifussFFarwellJHolmesGInfantile spasms. Comparative trial of nitrazepam and corticotropinArch Neurol198643110711103022694
   PubMedGoogle Scholar
• TrigoFFChatMMartyAEnhancement of GABA release through endogenous activation of axonal GABA(A) receptors in juvenile cerebellumJ Neurosci200711142746:124521246318003823
   PubMed Web of Science ®Google Scholar
• AicardiJMumfordJPDumasCWoodSVigabatrin as initial therapy for infantile spasms: A European retrospective surveyEpilepsia1996376386428681895
   PubMed Web of Science ®Google Scholar
• AppletonREPetersACBMumfordJPShawDERandomized, placebo-controlled study of vigabatrin as first-line treatment of infantile spasmsEpilepsia1999401627163310565592
   PubMed Web of Science ®Google Scholar
• VigevanoFCilioMRVigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective studyEpilepsia199738127012749578521
   PubMed Web of Science ®Google Scholar
• EltermanRDShieldsWDMansfieldKAUS Infantile Spasms Vigabatrin Study GroupRandomized trial of vigabatrin in patients with infantile spasmsNeurology2001571416142111673582
   PubMed Web of Science ®Google Scholar
• EltermanRDCollinsSDShieldsDMansfieldKANakagawaJEfficacy of vigabatrin in subjects with infantile spasmsEpilepsia200546Suppl 814215987269
   PubMed Web of Science ®Google Scholar
• ShieldsDCollinsSDEltermanRDNakagawaJMansfieldKAAES and safety of vigabatrin in subjects with infantile spasmsEpilepsia20054616116302891
   PubMed Web of Science ®Google Scholar
• ChironCDulacOBeaumontDPalaciosLPajotNMumfordJTherapeutic trial of vigabatrin in refractory infantile spasmsJ Child Neurol19916Suppl 22S522S59
   Google Scholar
• LuxALEdwardsSWHancockEThe United Kingdom infantile spasms study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: A multicentre randomized trialLancet Neurol2005471271716239177
   PubMed Web of Science ®Google Scholar
• ChironCDumasCJambaqueIMumfordJDulacORandomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosisEpilepsy Res1997263893959095401
   PubMed Web of Science ®Google Scholar
• SankarRSpenceSJVisual field defects and other ophthalmological disturbances associated with vigabatrinDrug Saf20012438540411419565
   PubMed Web of Science ®Google Scholar
• CubellsJFBlanchardJSMakmanMHThe effects of in vivo inactivation of GABA-transaminase and glutamic acid decarboxylase on levels of GABA in the rat retinaBrain Res19874192082153676726
   PubMed Web of Science ®Google Scholar
• NealMJCunninghamJRShahMAYazullaSImmunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retinaNeurosci Lett19899829322710396
   PubMed Web of Science ®Google Scholar
• DubocAHanoteauNSimonuttiMVigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in ratsAnn Neurol20045569570515122710
   PubMed Web of Science ®Google Scholar
• CrookDKPowDVAnalysis of the distribution of glycine and GABA in amacrine cells of the developing rabbit retina: A comparison with the ontogeny of a functional GABA transport system in retinal neuronsVis Neurosci1997147517639279003
   PubMed Web of Science ®Google Scholar
• WildJMAhnHSBaulacMVigabatrin and epilepsy: Lessons learnedEpilepsia2007481318132717635558
   PubMed Web of Science ®Google Scholar
• Gross-TsurVBaninEShaharEShalevRSLahatEVisual impairment in children with epilepsy treated with vigabatrinAnn Neurol200048606410894216
   PubMed Web of Science ®Google Scholar
• IannettiPSpaliceAMassimo PerlaFVisual field constriction in children with epilepsy on vigabatrin treatmentPediatrics200010683884211015531
   PubMed Web of Science ®Google Scholar
• GailyEJonssonHLappiMVisual fields at school-age in children treated with vigabatrin in infancyEpilepsia20095020621619215279
   PubMed Web of Science ®Google Scholar
• SergottRCWhelessJWSmithMCEvidence-based review of recommendations for visual function testing in patients treated with vigabatrinNeuro-Ophthalmology2010342035
   Web of Science ®Google Scholar
• JammoulFWangQNabboutRTaurine deficiency is a cause of vigabatrin-induced retinal phototoxicityAnn Neurol2009659810719194884
   PubMed Web of Science ®Google Scholar
• JammoulFDégardinJPainDTaurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal ratsMol Cell Neurosci20104341442120132888
   PubMed Web of Science ®Google Scholar
• PearlPLVezinaLGSanetoRPCerebral MRI abnormalities associated with vigabatrin therapyEpilepsia20095018419418783433
   PubMed Web of Science ®Google Scholar
• WhelessJWCarmantLBebinMMagnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsyEpilepsia20095019520519054414
   PubMed Web of Science ®Google Scholar
• MilhMVilleneueveNChaponFTransient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrinJ Child Neurol20092430531519258289
   PubMed Web of Science ®Google Scholar
• SankarRWasterlainCGIs the devil we know the lesser of two evils? Vigabatrin and visual fieldsNeurology1999521537153810331674
   PubMed Web of Science ®Google Scholar
• VlesJSHvan der HeydenAMHGGhijsATroostJVigabatrin in the treatment of infantile spasmsNeuropediatrics1993242302318232783
   PubMed Web of Science ®Google Scholar
• AppletonREMontiel-ViescaFVigabatrin in infantile spasms – why add onLancet19933419628096297
   PubMed Web of Science ®Google Scholar
• AppletonREA simple, effective and well-tolerated treatment regime for West syndromeDev Med Child Neurol1995371851877851675
   PubMed Web of Science ®Google Scholar
• KwongLVigabatrin as first line therapy in infantile spasms: Review of seven patientsJ Paediatr Child Health1997331211249145354
   PubMed Web of Science ®Google Scholar
• CovanisAThrodorouVLadaCSkiadasKLoliNThe first-line use of vigabatrin to achieve complete control of infantile spasmsJ Epilepsy199811265269
   Google Scholar
• VilleneuveNSouffletCPlouinPChironCDulacOTreatment of infantile spasms with vigabatrin as first-line therapy and in monotherapy: Apropos of 70 infantsArch Pediatr199857317389759271
   PubMed Web of Science ®Google Scholar
• SiemesHBrandlUSpohrH-LVolgerSWeschkeBLong-term follow-up study of vigabatrin in pretreated children with West syndromeSeizure199872932979733404
   PubMed Web of Science ®Google Scholar
• WohlrabGBoltshauserESchmittBVigabatrin as a first-line drug in West syndrome: Clinical and electrographic outcomeNeuropediatrics1998291331369706623
   PubMed Web of Science ®Google Scholar
• CossettePRivielloJJCarmantLACTH versus vigabatrin in infantile spasms: A retrospective studyNeurology1999521691169410331702
   PubMed Web of Science ®Google Scholar
• GranströmMLGailyELiukkonenETreatment of infantile spasms: Results of a population-based study with vigabatrin as the first drug for spasmsEpilepsia19997950957
   Web of Science ®Google Scholar
• KooBVigabatrin in the treatment of infantile spasmsPediatr Neurol19992010611010082337
   PubMed Web of Science ®Google Scholar
• FejermanNCersosimoRCaraballoRVigabatrin as a first-choice drug in the treatment of west syndromeJ Child Neurol20001516116510757471
   PubMed Web of Science ®Google Scholar
• NabboutRMelkiIGerbakaBDulacOAkatcherianCInfantile spasms in Down syndrome: Good response to a short course of vigabatrinEpilepsia2001421580158311879370
   PubMed Web of Science ®Google Scholar
• MitchellWGShahNSVigabatrin for infantile spasmsPediatr Neurol20022716116412393124
   PubMed Web of Science ®Google Scholar
• LuxALEdwardsSWHancockEThe United Kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trialLancet20043641773177815541450
   PubMed Web of Science ®Google Scholar
• AkmanCIChribogaCAFreyerRCappellJEmersonRLearyLSymptomatic infantile spasms response to antiepileptic treatment and short-term outcomeEpilepsia200546Suppl 8167
   Google Scholar
• AuvinSSankarRRhoJMSankarRStafstromCEAntiinflammatory treatments for seizure syndromes and epilepsyEpilepsy: Mechanisms, Models, and Translational PerspectivesNew York, NYCRC Press/Taylor and Francis2010
   Google Scholar